Additionally, all tumors demonstrated somatic loss of expression in one of the four mismatch repair proteins (MSH2, MSH6, MLH1, or PMS2) resulting in mismatch repair deficiency. Here, MSH6 is linked to mismatch repair cancer syndrome 1.